The Food and Drug Administration OK’d Gilead Sciences’ (GILD) hepatitis C pill Sovaldi late Friday, an expected but still key step for a drug widely seen as a mega-blockbuster. Analysts foresee a very rapid uptake, with Sovaldi sales of $1.7 billion next year and $8 billion in 2018. That would make it one of the world’s best-selling drugs. Gilead shares edged higher late Friday after closing up 1%. The drug ended up with a
Amazon.com said Thursday that it’s made huge progress this holiday season in freeing consumers from “wrap rage,” the challenge of cutting through thick plastic clamshell cases or dealing with a forest of wire ties to get at gifts. The No. 1 e-commerce company says it’s helping the environment in the process. Amazon (AMZN), which has been working for five years with big manufacturers under its Frustration-Free Packaging initiative,
The Supreme Court declined Monday to hear a case brought by Amazon challenging a New York law that allows authorities to collect sales taxes from Internet retailers even without a direct physical presence in the state. The court also turned aside a similar appeal by Overstock.com. The high court’s refusal to revisit the issue ratchets up pressure on Congress to pass legislation requiring e-tailers to collect sales taxes in all